X-Received: by 2002:a05:6214:27cb:b0:472:efee:1719 with SMTP id ge11-20020a05621427cb00b00472efee1719mr6455437qvb.57.1656933398480;
Mon, 04 Jul 2022 04:16:38 -0700 (PDT)
X-Received: by 2002:a05:6808:4cd:b0:335:6fbe:e1fd with SMTP id
a13-20020a05680804cd00b003356fbee1fdmr16168438oie.48.1656933398217; Mon, 04
Jul 2022 04:16:38 -0700 (PDT)
Path: i2pn2.org!i2pn.org!weretis.net!feeder6.news.weretis.net!news.misty.com!border2.nntp.dca1.giganews.com!nntp.giganews.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: comp.lang.javascript
Date: Mon, 4 Jul 2022 04:16:38 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=104.223.104.235; posting-account=hkCnjwoAAAD931FDYXyewH5MrRYaKfqN
NNTP-Posting-Host: 104.223.104.235
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <778db316-65f7-4b75-ae07-f19c971eaa6bn@googlegroups.com>
Subject: (PDF) Peptide-based Drug Discovery by Ved Srivastava
From: hesterholt2@gmail.com (Hester Holt)
Injection-Date: Mon, 04 Jul 2022 11:16:38 +0000
Content-Type: text/plain; charset="UTF-8"
Lines: 1